TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Clinical feasibility assessed by MD opinions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical feasibility assessed by RN opinions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: proportion of subjects achieving 5% weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: changes in waist circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Patient recruitment rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: ANC visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Immunisation coverage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in cross-sectional skeletal muscle mass area on the third vertebral level (L3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Skin blood flow variations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Inter- and intra-observer variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Recruitment Retention Rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time Required to Recruit to Target
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Success Rate of Educational Intervention
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Data collection feasibility
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Stress hyperglycemia Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximum Observed Plasma Concentration of M1774
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Curve from Time Zero to the Time of the Last Quantifiable Concentration of M1774
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abdominal ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Edema assessed by Ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with a severe AE
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients who withdraw due to AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Change in neutrophil function as assessed by Neutrophil extracellular trap (NET) formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in phagocytic index of neutrophils
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in neutrophil function as assessed by reactive oxygen species (ROS) production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Chedoke Arm and Hand Activity Inventory 9 (CAHAI-9) Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Box and Block (BBT) Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Bronchospiration pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: Positive valence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart rate deceleration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total endotracheal intubation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Acceptance of the iCCaRE Virtual Robot Assistant (ViRA)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usability of the iCCaRE ViRA
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: cumulative amount of time spent in Hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ultrasound enthesis differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensitivity and specificity of sternomental displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of fibrinous pleurisy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in glymphatic function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of echocardiographic measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: changes from baseline in Brain activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes from baseline serum markers of inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Major access site complications
Endpoint domain: Adverse events/effects
Primary endpoint: Postural Assessment Scale For Stroke Patients (PASS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eastman Interdental Bleeding Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decompression sickness clinical symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in melatonin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with local and systemic adverse events (AEs) and serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of adverse events and dose limiting toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Beck rating scale for suicidal ideation (BSI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence and severity of neonatal acute respiratory distress syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence and severity of pulmonary edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mortality of NARDS
Endpoint domain: Mortality/survival
Primary endpoint: Frequency of food items remaining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of healthy and unhealthy items remaining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Loss aversion score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: New Mobility Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mitochondrial area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mitochondrial cristae density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of infection at 90-day post-op follow-up
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum Tolerated dose of ZV0203
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remote blood pressure measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Remote body weight measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of AE after CAR-T infusion
Endpoint domain: Adverse events/effects
Primary endpoint: Change in the level of psychological flexibility
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in the degree of overall symptomatic distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in post-traumatic symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in the degree of societal recovery
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: thickness of Retinal nerve fiber layer (RNFL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: thickness of Macula
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Choroidal Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Diagnostic performance of CT attenuation parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of accidental spillages
Endpoint domain: Adverse events/effects
Primary endpoint: Muscle Reaction Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hand Dexterity (Moberg Pick-Up Test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grip Strength (Measured Using Jamar Electronic Dynamometer)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with TKA using KOOS JR Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient satisfaction with TKA using Oxford Knee Score (OKS) Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient satisfaction with TKA using Forgotten Joint Score (FJS) Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient recovery from TKA using time from hospital stay to discharge
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Patient recovery from TKA by measuring number of outpatient visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Patient recovery from TKA by measuring number of PT visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Completion of PET-MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Sensitivity and Specificity of UCAD analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Decrease in the symptoms of General Anxiety Disorder (GAD-7)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in the score of The Pittsburgh Sleep Quality Index (PSQI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Increase in the score of the Professional Quality of Life Measure (ProQOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Composite Score of PSS-10, PHQ-9, and GAD-7 at Baseline
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Composite Score of PSS-10, PHQ-9, and GAD-7 at Post-Intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Composite Score of PSS-10, PHQ-9, and GAD-7 at Follow-Up
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in aerosol deposition in fibrotic lung regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of participants with mRS score of 0-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline body height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects achieving an ASAS40 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pregnancy discomforts
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: EBOV glycoprotein (GP)-specific T and B cell Spot Forming Units
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Tumor presence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Presence of falls
Endpoint domain: Adverse events/effects
Primary endpoint: Area Under the Plasma Concentration versus Time Curve From Time Zero to Time of the Last Measurable Concentration (AUC[0-last])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apparent Elimination Half-life (T1/2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in interferon activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of ITP patients in which COVID-19 occurs
Endpoint domain: Adverse events/effects
Primary endpoint: Number of COVID-19 patients developing ITP
Endpoint domain: Adverse events/effects
Primary endpoint: Mean height of basal bone in the symphysial area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing of rotator cuff tear
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Speech Production Ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Motor Control Ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of serious adverse drug reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Patients' tolerability of adverse drug reactions
Endpoint domain: Adverse events/effects
Primary endpoint: HLA-A*0201-restricted LRPAP21-30-specific CD8+ T-cell reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Low Density Lipoprotein-Cholesterol (LDL-C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Duration of post-anesthesia care unit recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent flow mediated dilatation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean number of emergency-treatments administered
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Lipid Profile total cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Superoxide Dismutase Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Optimal concentration of INKmune therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of INKmune therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Change in pain level using the VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of gastroesophageal reflux disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of participants with clinically significant changes in 12-lead Electrocardiogram (ECG) readings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with clinically significant changes in physical examinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pediatric Quality of Life Inventory 4.0 (PedsQL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: The Self-Efficacy for School Physical Activity Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Severity of dynamic narrowing on Flexible Bronchoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Severity of Maximal Airway Change (MAC) on DA-CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Severity of Excessive dynamic airway collapse (EDAC) on DA-CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of group sessions attended
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Concordance in detection of swallowing disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of different types of optic nerve course
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of occurrence and severity of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in urine volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time-weighted average in hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Cycloplegic subjective refraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with LVEF or LVEDV deterioration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in home BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Early detection of bladder cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: % of affected/unaffected fetuses correctly classified
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: % of inconclusive results
Endpoint domain: Adverse events/effects
Primary endpoint: target lesion ISR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Women's beliefs about breast self-exam level
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Genetic Alterations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in PCA-specific anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Post EUS-FNA PCL infection rate
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Brief Pain Inventory score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Sensitivity and Specificity of PanTum detect Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time From Emergency Room Arrival to Initiation of Endovascular Stroke Therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiovascular-related hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with response to TMS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biochemical determinants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with SVR12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Movement Disorders Society Sponsored Unified Parkinson's Disease Rating Scale (MDS-UPDRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parkinson's Disease Questionnaire with 39 items
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of children with neurological, orthopedic or sensory sequelae
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Activity changes in the dorso-fronto-limbic brain network
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Symptom severity as measured by MDASI-SP
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Oxygen ejection fraction (OEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cerebral metabolic rate of oxygen (CMRO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of Not-on-NA participants without loss of parent study primary outcome (PSPO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of On-NA participants rolling over from studies 209668 and 209348 without loss of functional cure (FC) after NA-cessation in study 206882
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of On-NA participants rolling over from study 217023 without loss of FC after NA-cessation in study 206882
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of NA-cessated participants rolling over from studies 202009 and 219288 without loss of FC after NA-cessation in the parent study
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Local and Systemic Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Local and Systemic Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Fat reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Healthy Lifestyle Behaviors
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change of Diabetes Self-Management
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Colorectal Cancer Screening completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: TSH response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Accuracy of machine learning prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pressure-pain threshold measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to resolution of ARI symptoms/events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose for Radiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anti-drug antibodies (ADA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: White blood cell (WBC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Steatohepatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Rate of overweight/obesity at 2 years old
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of overweight/obesity at 7 years old
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes